Major Ingredients

BetaIoc-XR-100: Each extended release tablet containsMetoprolol Succinate USP 95mg (eqv. ToMetoprolol Tartrate100mg).

Major Functionality

Hypertension: Extended release Metoprolol Succinate tablet is indicated for thetreatment of hypertension. It may be used alone or in combination with other antihypertensive agents.Angina Pectoris: Extended release Metoprolol Succinate tablet is indicated in the long-term treatmentof angina pectoris. Heart Failure: BetaIoc-XR Tablet is indicated for the treatment of stable, symptomatic (NYHA Class Ilor Ill) heart failure of ischemic, hypertensive, or cardiomyopathic origin.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.